DePuy Synthes launches cellular allograft for spinal fusion surgery

DePuy Synthes, in collaboration with LifeNet Health, has launched ViviGen Formable cellular bone matrix, a second-generation cellular allograft to assist with bone formation during spinal fusion surgery.

According to a company press release, the ViviGen Formable creates a putty-like consistency and its fibers interconnect to achieve formable handling for open void cases, such as posterolateral fusion. This handling reportedly allows surgeons to mold the allograft, helping the ViviGen Formable to conform to the surgical site.

DePuy Synthes has an exclusive agreement to market and promote ViviGen and ViviGen Formable.

 

Reference:

www.depuysynthes.com

 

DePuy Synthes, in collaboration with LifeNet Health, has launched ViviGen Formable cellular bone matrix, a second-generation cellular allograft to assist with bone formation during spinal fusion surgery.

According to a company press release, the ViviGen Formable creates a putty-like consistency and its fibers interconnect to achieve formable handling for open void cases, such as posterolateral fusion. This handling reportedly allows surgeons to mold the allograft, helping the ViviGen Formable to conform to the surgical site.

DePuy Synthes has an exclusive agreement to market and promote ViviGen and ViviGen Formable.

 

Reference:

www.depuysynthes.com